New injection for blood cancers enters first human tests
NCT ID NCT06756451
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new drug called RJK-RT2831 in 71 adults with blood cancers. The main goals are to check safety, find the right dose, and see if the drug shows any early signs of working. Participants must be 18 to 74 years old and in good enough health to follow the study plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Hebei University
RECRUITINGBaoding, Hebei, 071000, China
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, 510080, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450003, China
-
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
RECRUITINGTianjin, Tianjin Municipality, 300020, China
-
Shenzhen People's Hospital
RECRUITINGShenzhen, Guangdong, 518020, China
-
Southern Medical University Nanfang Hospital
RECRUITINGGuangzhou, Guangdong, 510515, China
-
Tangshan Central Hospital
RECRUITINGTangshan, Hebei, 063008, China
-
The Affiliated Hospital of Guilin Medical University
RECRUITINGGuilin, Guangxi, 541001, China
-
The First Affiliated Hospital of Guangxi Medical University
RECRUITINGNanning, Guangxi, 530021, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of USTC
RECRUITINGHefei, Anhui, 230001, China
-
The First Affiliated Hospital of Xi 'an Jiaotong University
RECRUITINGXi'an, Shaanxi, 710061, China
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110001, China
-
The Second Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, 230601, China
-
Zhongda Hospital Southeast University
RECRUITINGNanjing, Jiangsu, 210009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Could muscle loss predict blood cancer outcomes?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?